Understanding JAK inhibitor toxicity
1. 系统已在2025-10-16 15:35:39对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
A Sivadas, KW Byram, M Valdebran, T Beck
Journal of the American Academy of …
jaad.org
… Ruxolitinib, the first JAK inhibitor approved in 2011, … -documented adverse effects of ruxolitinib, including myelosuppression, … Ruxolitinib and tofacitinib exhibited broad off-target activity, …

